ABBOTT LABORATORIES — Director's Dealing 2021

Aug 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2021-08-03

Reporting Person: Karam Sammy (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-03	Common shares without par value	M	8000	$75.90	Acquired	30926	Direct
2021-08-03	Common shares without par value	S	8000	$122.50	Disposed	22926	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-03	Option (right to buy)	$75.90	M	8000	Disposed	2029-02-21	Common Shares (8000)	Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.